qRT-PCR showed the increased CCL2 expression and the decreased VEGFA level in NS rats compared with that in control rats (P < 0.05), and there were no significant changes after FHD or/and 740Y-P treatment (Figures 9(a) and 9(b)). This evidence concerns the gene CCL2 and hypoalphalipoproteinemia, primary, 1.